Tekcapital plc MicroSalt placement of SaltMe Low Sodium Crisps
19 Octubre 2023 - 1:00AM
RNS Non-Regulatory
TIDMTEK
Tekcapital plc
19 October 2023
19 October 2023
Tekcapital Plc
("Tekcapital", the "Company" or "the Group")
Portfolio Company Update:
MicroSalt(R) gains placement of its SaltMe! Low Sodium
Crisps
in Longs Drug Stores
Tekcapital Plc (AIM: TEK) the UK intellectual property
investment group focused on creating valuable products that can
improve people's lives, is pleased to announce that Longs Drugs a
leading drug store chain in Hawaii has committed to place
MicroSalt's SaltMe! Crisps in their stores.
MicroSalt(R) provides a much-needed option that allows food
manufacturers and consumers to slash the sodium content of their
food without impacting the flavour. With 31% of adults worldwide
suffering from high blood pressure and other cardiovascular
diseases - and with efforts mounting around the globe to lower the
sodium content in prepared and packaged foods - MicroSalt(R) is
offering a truly timely solution.
"We are very excited about the placement of our SaltMe Low
Sodium Crisps with the Longs Drug Chain. Excess sodium consumption
is one of the leading contributors to hypertension and heart
disease. Placements like this are the best way to provide consumers
with great tasting, healthy products with less sodium," said Rick
Guiney, CEO of MicroSalt(R).
About Longs Drugs
Longs Drugs is an American drug store chain owned by parent
company CVS Health, with approximately 70 drugstores throughout the
state of Hawaii. Longs Drugs was acquired by parent company CVS
Health in 2008. To learn more please visit
https://en.wikipedia.org/wiki/Longs_Drugs .
About MicroSalt(R)plc
MicroSalt, is the developer and manufacturer of a proprietary
low-sodium salt called MicroSalt(R). We are passionate about
improving peoples' lives with better-for-you seasonings and snacks
by taking the lead in the industry by providing the best low-sodium
salt solution, based on the mechanical transformation of the salt
particle itself. This solution is the only one that delivers real
salt flavour because it is salt. Our new patented technology
produces salt crystals that are approximately one hundred times
smaller than typical table salt, delivering a powerful saltiness as
the micro-grains dissolve in the mouth, with approximately 50% less
sodium consumption. Additionally, the ultra-small particle size
enhances product adhesion, which reduces waste and provides
improved flavor consistency. MicroSalt(R) and SaltMe(R) are
registered trademarks of MicroSalt Inc.
To learn more about MicroSalt please visit
https://www.microsalt.co
Tekcapital owns approximately 87% of the share capital of
MicroSalt plc and 92% of MicroSalt Inc. its U.S. subsidiary.
About Tekcapital plc
Tekcapital creates value from investing in new,
university-developed discoveries that can enhance people's lives
and provides a range of technology transfer services to help
organisations evaluate and commercialise new technologies.
Tekcapital is quoted on the AIM market of the London Stock Exchange
(AIM: symbol TEK) and is headquartered in the UK. For more
information, please visit www.tekcapital.com .
LEI: 213800GOJTOV19FIFZ85
For further information, please contact:
Tekcapital Plc Via Flagstaff IR
Clifford M. Gross, Ph.D.
SP Angel Corporate Finance LLP (Nominated
Adviser and Broker) +44 (0) 20 3470 0470
Richard Morrison / Charlie Bouverat (Corporate
Finance)
Rob Rees (Corporate Broking)
Flagstaff Strategic and Investor Communications +44 (0)207 129
1474
Tim Thompson/Andrea Seymour/Fergus Mellon
This press release is for informational purposes only. The
information herein does not constitute investment advice nor an
offer to invest and may contain statements related to our future
business and financial performance and future events or
developments involving MicroSalt that may constitute
forward-looking statements. These statements may be identified by
words such as "expect," "look forward to," "anticipate" "intend,"
"plan," "believe," "seek," "estimate," "will," "project" or words
of similar meaning. We may also make forward-looking statements in
other reports, in presentations, in material delivered to
customers, stakeholders and in press releases. In addition, our
representatives may from time to time make oral forward-looking
statements. Such statements may be based on the current
expectations and certain assumptions of MicroSalt's and/or
Tekcapital's management. Please note that these are subject to a
number of risks, uncertainties and factors, including, but not
limited to those described in various disclosures. Should one or
more of these risks or uncertainties materialize, or should
underlying expectations not occur or assumptions prove incorrect,
actual results, performance or achievements of MicroSalt or
Tekcapital may vary materially from those described explicitly or
implicitly in the relevant forward-looking statement. Neither
MicroSalt nor Tekcapital intends, nor assumes any obligation, to
update or revise these forward-looking statements in light of
developments which differ from those anticipated.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRANKFBBKBDBNKD
(END) Dow Jones Newswires
October 19, 2023 02:00 ET (06:00 GMT)
Tekcapital (LSE:TEK)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Tekcapital (LSE:TEK)
Gráfica de Acción Histórica
De May 2023 a May 2024